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Introduction
The affinity of human papillomavirus (HPV) to squa-
mous epithelium has been well documented, especial-
ly associated witharrising benign, precancerous lesions
and invasive squamous cell carcinoma of the cervix,
oral, anogenital region, carcinomas of the head and
neck and upper aerodigestive tract [1]. The most com-
mon lesions of the conjunctical and eyelid epithelium
are papillomas and squamous cell cancers with the eti-
ology associated with external irritants such as UV
irradiation, wind, and dust. Patients, usually men older
than 50 years, frequently reported a history of a previ-
ous pinguecula, pterygium, or actinic keratosis of the
conjunctiva [2,3]. However DNA for HPV types 6 and
11 is consistently demonstrable in benign papillomas
of the conjunctiva. Types 6 and 11 are probably
responsible for the majority of the benign papillomas
of human conjunctiva. Only a few studies on the asso-
ciation of conjunctival carcinomas with HPV have
been reported, and the results are inconsistent [3-5]. 
P53 tumor suppressor acts as transcriptional activa-
tor, controlling the expression of a variety of genes
important in cell cycle regulation and apoptosis.
Approximately half of all cases of human cancer
maybe attributed to a defective p53 protein. Most of
these are caused by missence mutations in the p53
gene, changing one amino acid in the protein to anoth-
er. This may alter the binding of the protein to DNA or
to the transcription factors, corrupting the signal from
p53 to the cell [6-8]. 
The aim of the study was to evaluate the DNA pres-
ence of human papillomavirus using two different
methods as well as the p53 gene mutation in benign
and malignant lesions of the eyelid and conjunctival
squamous epithelium.
Materials and methods
A series of 83 lesions of the conjunctival and eyelid epithelium
was estimated: 45 squamous cell papillomas, including 7 cases
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with koilocytic dysplasia, 11 squamous cell cancers and 27 basal
cell cancers. The patients' age ranged from 18 to 94 years in
papilloma group, and from 42 to 87 years in cancer group. 92.1%
of the cancers and 73.3% of papillomas were located on the eye-
lid. Formalin fixed, paraffin embedded sections of each lesion
were stained with haematoxylin and eosin and examined to con-
firm the diagnosis. The immunohistochemical reaction was per-
formed to present the DNA of human papilomavirus. Rabbit anti-
bovine papillomavirus antibody was purchased from Dako.
Immunohistochemical staining was performed by the avidin-
biotin complex method. The sections were deparaffinised,
endogenous peroxidase was blocked by incubation of the slides
for 10 minutes in 1% NaIO4, and, after being washed, the slides
were incubated with primary antibodies (dilution 1:100). The
slides were then exposed to a biotinylated anti-rabbit
immunoglobulin antiserum (dilution 1:50), avidin (dilution
1:100) and biotinylated horseradish peroxidase complex. The
peroxidase reaction was performed by incubating the slides in
0.005% H2O2 and 0.02% 3' diaminobenzidine tetrahydrochloride
for 10 minutes. The specimens of cervix with high dysplasia
(CIN 3) were used as a positive control, and phosphate buffered
saline instead of primary antibody as the negative control.
To estimate the DNA presence of huaman papillomavirus the
polymerase chain reaction was performed. DNA was isolated from
the paraffin- embedded tissues with GenElute Mammalian Genom-
ic DNA Kit (Sigma). The PCR-RFLP reaction was performed with
the proper primers pairs to benign and malignant types of human
papillomaviruses (TaKaRa). The products of PCR-RFLP reactions
were visualized on the 6% polyacrylamid gels. 
The p53 gene mutation was evaluated by using PCR- SSCP
method. Exons 5-8 of the p53 gene were PCR-amplified inde-
pendently using the oligonucleotide primers shown in Table 1. 
40 PCR cycles comprising denaturation, annealing and elonga-
tion at 96°C for 30 sec, 57.5°C (e-5), 58.2°C (e-6), 57.4°C (e-7),
53.05°C (e-8), and 72°C for 30 sec were carried out. The PCR
products were denaturated with the loading dye buffer at 95°C for
10 minutes and applied to 6% non-denaturating polyacrylamide
(acrylamide-bisacrylamide 49:1) gel containing 5% glycerol and
electrophoresed in cooling chamber in 20°C at 30 mA through 30
hours. 
Fig. 1. Squamous cell papilloma of the conjunctiva. Cytoplasmat-
ic immunohistochemical reaction with HPV antibodies (Dako)
observed mostly in the basal layer of the epithelium. Original mag-
nification ×200.
Fig. 2. Squamous cell carcinoma of the conjunctiva. Immunohis-
tochemical reaction with HPV antibodies observed in the nuclei of
the neoplastic cells. Original magnification ×200.
Fig. 3. PCR-RFLP reaction products for malignant type (16,18)
human papillomaviruses (line 7 and 8) used primers pU-1M/pU-
2R (231-268 pb). 
Fig. 4. PCR-SSCP reaction products- p53 mutation in 5 exon (line
2,7). Line 9 pBR322 III Hae.
Results
The products of PCR-RFLP were obtained only with
using the primers pairs to malignant types of HPV
(Fig. 3). 
HPV DNA was detected in 4 out of 45 papillomas
(8.8%), 1 out of 11 squamous cell cancers (9.1%), and
1 out of 27 basal cell cancers (3.7%).
Human papillomavirus positive immunohistochem-
ical reaction was observed in 12 out of 45 papillomas
(26.6%) (Fig 1), 2 out of 27 basal cancers (7.4%) and
1 out of 11 squamous cell cancers (9.1%) (Fig. 2). 
All PCR-RFLP positive lesions showed also HPV-
positive immunostaining. All 7 cases with koilocytic
dysplasia was HPV positive using immunohis-
tochemocal reaction however only 2 cases using PCR-
RFLP method. 
P53 gene mutation was observed in 12 malignant
lesions including 6 out of 11 squamous cell cancers
(54.5%), mostly estimated as G1 and G2 and in 6 out
of 27 basal cell cancers (22.2%). The most frequent
mutation was occurred in exons 6 and 7 (Fig 4). 
In papillomas group p53 gene mutation was present
in 11 out of 45 cases (24.4%) also most commonly in
exons 6 and 7. 
In 5 out of 7 human papillomavirus- positive
lesions p53 gene mutation was also observed. 
Discussion
The recent data indicate the HPV infection as a pre-
dictive factor of the various lesion developments,
including benign and malignant lesions of the con-
junctiva and eyelid. However the studies performed
between 1986 and 2008 brought very various results of
the association between the type of the lesion and the
presence of HPV, as well as the differences of the
using methods. Naghashfar et al. [3] showed HPV in 1
out of 3 squamous cell papillomas, McDonell et al. [1]
all in 15 out of 23 papillomas, Mincione et al. [4] al in
2 out of 4 papillomas, Saegusa et al. [13] in 75% squa-
mous cell papillomas. Nakamura et al. [5] estimated 
17 patients with neoplastic lesions of the conjunctiva.
HPV particles were observed in 8 lesions including 
4 papillomas, 3 papillomas with koilocytic dysplasia
and in 1 in carcinoma in situ using immunohistochem-
ical reaction. Using in situ hybridization HPV DNA
was observed in 5 cases, in 4 cases HPV benign type
and 4 HPV malignant type using PCR-RFLP reaction. 
Our study proves PCR-RFLP reaction more sensi-
tive comparing to immunohistochemical reaction to
HPV estimation. Similar to Matsumoto et al. [6], Toth
at al. [8] and Eng et al. [9] in the recent studies the
HPV presence in squamous carcinomas ranged from
86% (Ateenyi-Agaba et al. [10]) to 0% (Eng et al. [9],
Newton et al. [12], and Tulvatana et al. [11]). In our
study a very low percentage of HPV-positive cases
might indicate other than viral etiology of benign and
malignant lesions of the conjunctiva and eyelid. How-
ever the various percentages of HPV positive lesions
in the recent data might be also associated with various
types of methods, in PCR-RFLP technique with differ-
ent types of primers, magnesium concentrations as
well as the used isolation techniques. It also might be
associated with geographical differentiations between
etiological factors such as life style, environmental
factors and genetic predispositions. 
In our present study we also evaluated the p53 gene
mutation, which seemed to be the most common event
in the squamous cancer development. Among all of the
conjunctiva and eyelid lesions the most important evi-
dence, which might lead to malignancy, occurred p53
mutation. Although in papilloma group p53 mutation
might be also an important cofactor especially in pro-
gression to dysplasia and cancer. In the recent data
only Ateenyi-Agaba et al. [10] observed p53 mutation
in 52% cases of squamous cell cancers. Also difficult
is to find evaluations associated with p53 mutation in
squamous cell papillomas, therefore our study gives an
important view to conjunctival and eyelid squamous
epithelium lesions development.
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